gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NUWEHealthcareElectromedical Equipment

Nuwellis, Inc. Common Stock (NUWE)

$5.27−10.83%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$5.27▼ 99.38% in range
Nov 4, 2025Low $2.90 · High $1319.85Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Nuwellis closed at $5.27 on Nov 4, down 10.83%, 99.6% below its 52-week closing high. Volume of 80.6K shares was 0.04× its 20-day average (below normal).

Split-adjusted performance: -16.5% over one month, -98.5% over six months, -99.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.97M, up 14.1% from a year earlier, with a net margin of -245.1%.

Short interest was 89.4K shares at the Oct 15 settlement, down 46.6% from the prior report (2.6% of float, 1.0 days to cover).

Market cap$2.1M405.3K shares
Revenue · quarter$2.0M+14.1% YoY
Diluted EPS$-239.76—
P/E · TTM—P/S 0.2×
Net margin-245.1%Gross 76.1%
Dividend yieldNone
52-week range2.90 – 1319.85−99.6% from high
Volume80.6K0.04× 20-day avg
Volatility · 60d589.4%Annualised
Short % of float2.6%1.0 days to cover
Net cash$3.9MCash $3.9M
Next earnings—Not scheduled
Split-adjusted performance
1W −6.9%1M −16.5%3M −64.1%6M −98.5%YTD −99.0%1Y −99.4%3Y −100.0%5Y −100.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum0
Revenue growth53
Net margin11
Value (low P/E)—
Size5

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →
Shares short89.4K−46.6% vs prior
Days to cover1.0Settled Oct 15
% of float2.6%
Short vol. 10d53.6%of daily volume

Closest peers by size in Electromedical Equipment

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NUWENuwellis$5.27−10.83%−98.5%+14.1%−245.1%—$2.1M
NXLNexalin Technology$1.56+1.30%−85.1%−82.8%−18412.7%—$1.6MCompare
NDRAENDRA Life Sciences$4.94+1.65%+1.6%———$7.4MCompare
IRIXIridex$0.7151+2.74%−31.2%−7.4%−10.1%—$12.6MCompare
QTIQT Imaging Holdings$2.19+1.39%−69.2%+103.2%−148.9%—$32.1MCompare
STEXStreamex$0.3610−5.00%−64.3%—−9968.5%—$42.0MCompare
POCIPrecision Optics$4.84+3.42%+2.8%+42.0%−1.2%—$53.2MCompare
ECORelectroCore$8.40+16.18%+26.1%+28.0%−32.4%—$75.7MCompare
HYPRHyperfine$0.7503+8.36%−56.6%+44.8%−238.2%—$79.6MCompare

News about Nuwellis

All news →
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric NephrologyGlobeNewswire Inc. · Oct 27, 2026▲ PositiveNuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewswire Inc. · Jul 31, 2026NeutralNuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)GlobeNewswire Inc. · Jun 26, 2026▲ PositiveNuwellis Announces Closing of $6.0 Million Registered Public OfferingBenzinga · Jun 9, 2026NeutralNuwellis, Inc. Announces First Quarter 2026 Financial ResultsGlobeNewswire Inc. · May 12, 2026▲ Positive

Quick answers

What does Nuwellis do?
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics.
What is NUWE's market cap?
$2.14M, based on the Nov 4 close of $5.27.
Does Nuwellis pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NUWE is sold short?
89.4K shares, 2.6% of float, as of Oct 15, 2026.
What sector is NUWE in?
Healthcare, in the Electromedical Equipment industry.

About Nuwellis

Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

HQ: Eden Prairie, MN38 employeesListed Feb 16, 2012nuwellis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology